The dual role of the helicobacter pylori at cancer of stomach

  • Л. Г. Баженов Republican specialised centre of surgery named after Academician V. Vahidov of the Republic of Uzbekistan
  • М. К. Кабулов Research department of Republican oncologic dispensary of the Ministry ofHealth of the Republic of Karakalpakstan
  • Т. Л. Баженова Republican specialised centre of surgery named after Academician V. Vahidov of the Republic of Uzbekistan
  • Т. М. Кабулов Research department of Republican oncologic dispensary of the Ministry ofHealth of the Republic of Karakalpakstan
Keywords: cancer protective action, carcinogenic action, Helicobacter pylori, cancer of stomach, carcinogenesis

Abstract

The contemporary data on the Helicobacter pylori (HP) role at the gastric cancer, the morbidity and the mortality due to it in different regions of the world are presented in the review. The results of the epidemiological studies on the connection between the HP-infection and the gastric cancer are analysed. The questions of pathogenesis of the HP-associated gastric cancer are discussed. The importance of the chronic HP-gastritis as a pre- cancerous disease, as well the conditions and consequences of the HP eradication are considered. The clinical and experimental data on the HP protective role at neoplastic processes are presented and discussed.

References

Аруин Л.И. Пищевод Баретта и Helicobacter pylori. РЖГГК, 2000, №2, Прил.10: 6-9.

Баженов Л. Г. Helicobacter pylori при гастродуоденальной патологии: выделение, микроэкология и чувствительность к антимикробным факторам: Дисс. ... д-ра мед. наук. - Ташкент, 1998. - 222 с.

Баженов Л.Г., Баженова Т.Л. Регрессия злокачественных опухолей с помощью микроорганизмов и перспективы использования этого феномена в медицинской практике. В кн.: Новые технологии в медицине. Санкт-Петербург, 2005: 111-113.

Рак. Информационный бюллетень ВОЗ N°297, 2006.

Роккас Ф. Инфекция Helicobacter pylori как фактор риска рака желудка: современные доказательства. РЖГГК, 2002; 3: 66-70.

Шкитин В.А. , Шпирна А.И. , Старовойтов Г.Н. Роль Helicobacter pylori в патологии человека. КМАХ, 2002; 2: 128-145.

Bajenov L.G., Rizaeva E.V., Artemova E.V. et al. Helicobacter pylori as inhibitor of neoplastic processes. Helicobacter, 2005, N10, 510.

Fischbach W., Chan A., Wong B. Helicobacter pylori and Gastric Malignancy. Helicobacter, 2005elicobacter pylori and Gastric MalignanceHHH; 10 (Suppl), 34-39.

Kamangar F., Dawsey S.M., Blaser M.J. et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst 2006; 98(20): 1445-1452.

Kuipers E.J. Helicobacter pylori, MALT lymphoma and gastric cancer. J Chemother 1999; 11 (Suppl 2):25.

Parsonnet J., Friedman G.D., Orentreich N., Vogelman H. Risk for gastric cancer in people with cagA positive or cagA negative Helicobacter pylori infection. Gut 1997; 40:297-301.

Periti P., Tonelli F., Capurso L. et al. Managing Helicobacter pylori infection in the new millennium: a review. J Chemotherapy 1999; 11(Suppl 4):3-55.
Published
2007-05-31
How to Cite
Баженов, Л., Кабулов, М., Баженова, Т., & Кабулов, Т. (2007). The dual role of the helicobacter pylori at cancer of stomach. Bulletin of the International Scientific Surgical Association, 2(1), 12-14. Retrieved from http://surgjournal.ru/index.php/BISSA/article/view/130
Section
Original Articles